Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Chenxing Pharmaceutical, frequently referred to in international markets as Dayspring, is a specialized pharmaceutical manufacturer based in Tianjin, China. The company focuses primarily on the development and production of ophthalmic and otorhinolaryngological medications, including eye drops, gels, and nasal sprays. As a key subsidiary of Grand Pharma (China) Co., Ltd., it leverages advanced manufacturing facilities to supply a wide range of treatments for conditions such as cataracts, dry eye, and ocular infections. Its commercial portfolio features well-known products like Pirenoxine Sodium and Levofloxacin ophthalmic solutions. The company is committed to maintaining high GMP standards and expanding its footprint in the global eye care market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dayspring Tianjin Pharmaceutical.